Initially there was no specific way to reverse the anticoagulant effect you know uh you know well um well um um of dabigatran in the event of a major bleeding event, well I mean you know you know uh like okay I mean unlike for warfarin, but a dabigatran antidote (idarucizumab) was approved by the FDA in 2015.